Skip to main content

Coalition for Epidemic Preparedness Innovations: Finance

Question for Foreign, Commonwealth and Development Office

UIN HL10236, tabled on 11 November 2020

To ask Her Majesty's Government, further to the Written Answer by Baroness Sugg on 6 November (HL9853), what outcomes they expect from their financial contribution to the Coalition for Epidemic Prepared Innovations; and how any outcomes will be assessed.

Answered on

25 November 2020

This year, the UK has contributed up to £250 million of UK aid to the Coalition for Epidemic Preparedness Innovations (CEPI) to develop vaccines against emerging epidemic diseases, including COVID-19. We expect this to deliver a portfolio of promising vaccine candidates that take into account the particular contexts, systems, and population needs of people in developing countries, and that people in ODA-eligible countries have access to them as soon as possible.

FCDO-funded programmes are subject to rigorous programme management procedures to monitor progress against expected outcomes, including routine financial and results reporting, audits, and annual reviews. For multi-donor funded organisations, including CEPI, the UK is an active participant in governance boards and committees, and works with other donors to set objectives, monitor performance, and ensure strong financial management and reporting.